Agilon, Baby Boy .

HRN: 24-76-94  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2024
AMPICILLIN 500MG (VIAL)
04/08/2024
04/15/2024
IV
150mg
Q12hrs
Neonatal Sepsis
Waiting Final Action 
04/08/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/08/2024
04/15/2024
IV
20mg
Q24hrs
Neonatal Sepsis
Waiting Final Action 
04/16/2024
CEFOTAXIME 500MG (VIAL)
04/16/2024
04/23/2024
IV
90mg
Q12
Neonatal Sepsis
Waiting Final Action 
04/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/17/2024
04/24/2024
IV
13.5mg
Q12H
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: